Makroskladniki diety a biotransformacja watrobowa

• Autorzy: Janus K
• Języki publikacji: PL

Słowa kluczowe

PL

ksenobiotyki; fizjologia zwierzat; enzymy; dieta niskobialkowa; biotransformacja watrobowa

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 1994
• Tom: 21
• Numer: 3
• Opis fizyczny: s.293-300,bibliogr.

Twórcy

autor

Janus K

• Akademia Rolnicza, Szczecin

Bibliografia

• 1. Alvares A.P., Anderson K.E., Conney A.H., et al.: Interactions between nutritional factors and drug biotransformation. Proc. Natl. Acad. Sci. USA 1986, 743, 2501.
• 2. Anderson K.E., Conney A.H., Kappas A.: Nutrition and oxidative drug metabolism in man; relative influence of dietary lipids, carbohydrate and protein. Clin. Pharmacol. Ther., 1979, 26, 493.
• 3. Anderson K.E., Conney A.H., Kapppas Al: Nutritional influences on chemical biotransfor-mations in human. Nutr. Rev., 1982, 40, 161.
• 4. Anderson K.E., Kappas A., Conney A.H., et al.: The influences of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects. J. Clin. Endocrinol. Metab., 1984, 59, 103.
• 5. Anderson K.E.: Influence of diet and nutrition on clinical pharmacokinetics. Clin. Pharmacokinet., 1988, 14, 325.
• 6. Anderson K.E., Mc Cleery R.B., Vesell E.S., et al.: Diet and cimetidine induce comparable changes in theophylline metabolism in normal subjects. Hepatology, 1991, 13, 941.
• 7. Anderson K.E., Pantuck E.J., Pantuck B.A., et al.: A controlled diet reduces intraindividual variability in drug disposition. Clin. Pharmacol. Ther., 1991, 49, 173.
• 8. Argyris T.S.: Additive effect of phenobarbital and high protein diet on liver growth in immature male rats. Dev. Biol., 1981, 25, 293.
• 9. Aszirmetov A.Ch., Krakovskij M.E.: Ispolzovanje antipirina dla ocenki aktivnosti fermentov monooksigenaznoj sistemy pieczeni. Lab. Delo., 1989, 34, 16.
• 10. Bidlack W.R., Brown R.C., Mohan C.: Nutritional parameters that alter hepatic drug metabolism, conjugation and toxicity. Fed. Proc., 1986, 45, 142.
• 11. Birt D.F., Schuldt G.H.: Dietary aminoacids and hepatic microsomal drug metabolism in Syrian hamsters. Drug Nutr. Inter., 1982, 1, 177.
• 12 Boyd E.M.: Benzylpenicillins toxicity in albino rats fed synthetic high starch versus high sugar diets. Chemotherapy 1980, 15, 1.
• 13. Butler L.E., Dauterman W.C.: Modulation of antipyrine and theophylline pharmacokinetics by adequate and excessive dietary protein in F344 rats. Nutr. Res., 1990, 10, 567.
• 14. Campbell T.C.: Nutrition and drug metabolizing enzymes. Clin. Pharmacol. Ther., 1977, 22, 699.
• 15. Campbell T.C., Hayes J.R.: The effect of quantity and quality of dietary protein on drug metabolism. Fed. Proc., 1976, 35, 2470.
• 16. Campbell T.C., Hayes J.R.: Role of nutrition in the drug metabolizing enzyme system. Pharmacol. Rev., 1984, 24, 171.
• 17. Conney A.H., Pantuck E.J., Kuntzman R., et al.: Nutrition and chemical biotransformation in man. Clin. Pharmacol. Ther., 1977, 22, 707.
• 18. Danhof M., Teunissen M.W.: Antipyrine as a model drug to assess oxidative drug metabolizing in man. Pharm. Int., 1984, 5, 11.
• 19. Dickerson J.W., Basu T.K., Parke D.V.: Activity of drug metabolizing enzymes in the liver of growing rats fed on diets high in sucrose, glucose and fructose. Proc. Nutr. Soc., 1971, 30, 27.
• 20. Feldman G.H., Hutchinson V.E., Pippenger C.E., et al.: Effect of dietary protein and carbohydrate on theophyline metabolism in children. Pediatrics 1980, 66, 956.
• 21. Feldman C.H., Hitchinson V.E., Sher T.H., et al.: Interaction between nutrition and theophylline metabolism in children. Ther, Drug Monit., 1982, 4, 69.
• 22. Hartshorn R.D., Damers L.M., Sultatos L.G., et al.: Effect of chronic parenteral carbohydrate administration on hepatic drug metabolism in the rat. Pharmacology 1979, 18, 103;
• 23. Hietanen E.: Modification of hepatic drug metabolizing enzymes activity and their induction by dietary protein. Gen. Pharmacol., 1990, 11, 443.
• 24. Homeida M., Karrar Z.A., Robert J.C.: Drug metabolism in malnourished children, a study with antipyrine. Arch. Dis. Childhood, 1979, 54, 299.
• 25. Kalow W.: Genetic variation in the human hepatic cytochrome P-450 system. Eur. J. Clin. Pharmacol., 1987, 31, 633.
• 26. Kappas A., Anderson K.E., Conney A.H., et al.: Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin. Pharmacol. Ther., 1976, 20, 643.
• 27. Kato R, Oshima T., Tomizawa S.: Toxicity and metabolism of drugs in relation to dietary protein. Jap. J. Pharmacol., 1988, 18, 356.
• 28. Krishnaswamy K, Kalameghan R., Naidu A.N.: Dietary influences on the kinetics of antipyrine and aminopyrine in human subject. Brit. J. Clin. Pharmacol., 1984, 17, 139.
• 29. Mehta S., Nain C.K., Sharma B., et al.: Drug metabolism in malnourished chidren. Prog. Clin. Biol. Res., 1991, 77, 739.
• 30. Mg Bodile M., Campbell T.C.: Effect of protein deprivation of male weanling rats on the kinetics of hepatic microsomal enzyme activity, J. Nutr., 1972, 102, 53.
• 31. Mucklow J.C., Caraher M.T., Henderson D.B., et al.: The relationship between individual dietary consituents and antipyrine metabolism. Brit. J. Clin. Pharmacol., 1982, 13, 481.
• 32. Pantuck E.J., Pantuck C.B., Weismann C., et al.: Effect of parenteral nutritional regimens on oxidative drug metabolism. Aneshtesiology 1984, 60, 534.
• 33. Pantuck E.J., Weismann C., Pantuck C.B., et al.: Effects of parenteral aminoacid nutritional regimens on oxidative and conjugative drug metabolism. Anesth. Analog., 1989, 69, 727.
• 34. Pantuck E.J., Pantuck C.B., Kappas A., et al.: Effects of protein and carbohydrate content of diet on drug conjugation. Clin. Pharmacol. Ther., 1991, 50, 254.
• 35. Penno M.B., Vesell E.S.: Monogenic control of variations in antipyrine metabolite formation; new polymorhpism of hepatic drug oxidation. J. Clin. Invest., 1983, 1698.
• 36. Peraino C., Lamar C., Pitot H.C.: Studies on the mechanism of carbohydrate represion in rat liver. Adv. Enzyms Regul., 1966, 4, 199.
• 37. Piroli R.J.: Influence of dietary protein and carbohydrate on oxidative biotransformation of drugs in normal adults and children with asthma. Nutr. Rev., 1981, 39, 232.
• 38. Reinke L.A., Belinsky S.A., Evans R.K., et al.: Conjugation of p-nitrophenol in the perfused rat liver; the effect of substrate concentration and carbohydrate reserves. J. Pharmacol. Exp. Ther. 1981, 217, 863.
• 39. Sanchez V., Newton D.J., Clark R.C., et al.: Drug metabolism in malnourished patients assessed by antipyrine clearance. Proc. Nutr. Soc., 1982, 41, 118.
• 40. Scholtens E., Baars A.J., Mulder G.J.: Effect of variation in the dietary supply of cysteine and methionine on liver concentrations of glutathione and active sulfate: relation to the metabolism of acetaminophen. J. Nutr., 1983, 113, 1363.
• 41. Sharma B., Mehta S., Nain C.K., et al.: Pharmacokinetics profile of antipyrine in young rhesus monkeys with protein-energy malnutrition. Drug Nutr. Interact., 1985, 3, 93.
• 42. Sonne J., Dragstedt J., Loft S., et al.: Influence of a very calorie diet on the clearance of oxazepam and antipyrine in man. Eur. J. Clin. Pharmacol., 1989, 36, 407.
• 43. Sthrother A., Throckmaortin J.K., Herzer C.: The influence of high sugar consumption by mice on the duration of action of barbiturates and in vitro metabolism of barbiturates, aniline and p-nitroanisole. J. Pharmacol. Exp. Ther., 1971, 179, 490.
• 44. Thompson P.J., Skypala I., Dawson S., et al.: The effect of diet upon serum concentration of theophyline. Brit. J. Clin. Pharmacol., 1983, 16, 267.
• 45. Varma D.R.: Influence of dietaiy protein on the disposition and metabolism of phenylbutazone in rats. Can. J. Physiol., 1980, 58, 231.
• 46. Vesell E.S.: Coplex effects of diet on drug disposition. Clin. Pharmacol. Ther., 1984, 36, 285.
• 47. Vessel E.S.: Polymorphism of antipyrine and theophylline metabolism in man; molecular and clinical implications. Xenobiotica 1986, 16, 401.
• 48. Vickeres F.F., Bowman T.A., Dvorchik B.H., et al.: On the antipyrine test in laboratory animals; studies in the dog and monkeys. Drug Metab. Disp., 1989, 17, 160.
• 49. Viktorov A.P., Rybak A.T.: Ispolzovanje antipirinogo testa pri izuczenji mikrosomalnogo okislenja lekarstvennych sredstv. Farmakol. Toksikol., 1990, 53, 74.
• 50. Wade A., Norred W.P.: Effect of dietaiy lipids on drug metabolizing enzymes. Fed. Proc., 1976, 35, 2475.
• 51. Weatherholte W.M., Campbell T.C., Webb R.E.: Effect of dietary protein level on the toxicity and metabolism of heptachlor. J. Nutr., 1969, 98, 90.
• 52. Wensing G., Ohnhaus E.E., Hoensch H.P.: Antipyrine elimination and hepatic microsomal enzyme activity in patients with liver disease. Clin. Pharmacol. Ther., 1990, 47, 698.
• 53. Wiela A., Orzechowska-Juzwenko K.: Fenazon i jego znaczenie jako wskaźnika wydolności metabolicznej wątroby. Post. Hig. Med. Dośw., 1987, 41, 136.
• 54. Young C.F., Yoo J.H.: Dietary effect on drug metabolism by the mixed function oxidase system. Pharmacol. Ther., 1988, 38, 53.